Kura Oncology (KURA) Equity Average (2011 - 2026)
Kura Oncology (KURA) reported Equity Average of $141.0 million for Q1 2026, down 63.75% year-over-year from $389.0 million in Q1 2025, and down 32.32% on a QoQ basis from $208.3 million in Q4 2025.
Kura Oncology (KURA) has 16 years of Equity Average data on file, last reported at $141.0 million in Q1 2026.
- Quarterly Equity Average fell 63.75% year-over-year to $141.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $141.0 million (down 63.75% YoY) and the FY2025 annual result came in at $293.9 million, down 27.52% from the prior year.
- Equity Average slipped to $141.0 million in Q1 2026 per KURA's latest filing, from $208.3 million in the prior quarter.
- Across five years, Equity Average topped out at $491.4 million in Q1 2022 and bottomed at $141.0 million in Q1 2026.
- The 5-year median for Equity Average is $419.9 million (2022), against an average of $391.2 million.
- The widest annual swing landed in 2024, when Equity Average gained 13.6%; it then plunged 63.75% in 2026.
- Tracing KURA's Equity Average over 5 years: stood at $419.9 million in 2022, then retreated by 1.51% to $413.6 million in 2023, then rose by 1.23% to $418.7 million in 2024, then slumped by 50.24% to $208.3 million in 2025, then slumped by 32.32% to $141.0 million in 2026.
- Per Business Quant, the three latest KURA Equity Average figures stand at $141.0 million (Q1 2026), $208.3 million (Q4 2025), and $274.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 141.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141.01 Mn |
| Dec 31, 2025 | 208.34 Mn |
| Sep 30, 2025 | 274.01 Mn |
| Jun 30, 2025 | 334.95 Mn |
| Mar 31, 2025 | 389.02 Mn |
| Dec 31, 2024 | 418.71 Mn |
| Sep 30, 2024 | 444.92 Mn |
| Jun 30, 2024 | 485.58 Mn |
| Mar 31, 2024 | 451.18 Mn |
| Dec 31, 2023 | 413.61 Mn |
| Sep 30, 2023 | 444.81 Mn |
| Jun 30, 2023 | 427.43 Mn |
| Mar 31, 2023 | 407.73 Mn |
| Dec 31, 2022 | 419.95 Mn |
| Sep 30, 2022 | 434.56 Mn |
| Jun 30, 2022 | 462.87 Mn |
| Mar 31, 2022 | 491.43 Mn |
| Dec 31, 2021 | 520.18 Mn |
| Sep 30, 2021 | 546.15 Mn |
| Jun 30, 2021 | 572.27 Mn |
| Mar 31, 2021 | 598.45 Mn |
| Dec 31, 2020 | 458.70 Mn |
| Sep 30, 2020 | 314.43 Mn |
| Jun 30, 2020 | 262.79 Mn |
| Mar 31, 2020 | 210.99 Mn |
| Dec 31, 2019 | 226.18 Mn |
| Sep 30, 2019 | 240.08 Mn |
| Jun 30, 2019 | 198.07 Mn |
| Mar 31, 2019 | 155.28 Mn |
| Dec 31, 2018 | 167.80 Mn |
| Sep 30, 2018 | 143.50 Mn |
| Jun 30, 2018 | 118.60 Mn |
| Mar 31, 2018 | 102.33 Mn |
| Dec 31, 2017 | 84.53 Mn |
| Sep 30, 2017 | 66.42 Mn |
| Jun 30, 2017 | 46.94 Mn |
| Mar 31, 2017 | 53.56 Mn |
| Dec 31, 2016 | 60.27 Mn |
| Sep 30, 2016 | 66.85 Mn |
| Jun 30, 2016 | 73.05 Mn |
| Mar 31, 2016 | 79.08 Mn |
| Dec 31, 2015 | 59.94 Mn |
| Sep 30, 2015 | 40.55 Mn |
| Jun 30, 2015 | 46.11 Mn |
| Mar 31, 2015 | 22.73 Mn |
| Dec 31, 2014 | -1.79 Mn |
| Sep 30, 2014 | -139,824.00 |
| Jun 30, 2014 | -133,166.50 |
| Mar 31, 2014 | -126,840.00 |
| Dec 31, 2013 | -119,082.00 |
| Sep 30, 2013 | -111,137.50 |
| Jun 30, 2013 | -104,693.50 |
| Mar 31, 2013 | -98,332.50 |
| Dec 31, 2012 | -90,515.00 |
| Sep 30, 2012 | -82,677.50 |
| Jun 30, 2012 | -76,537.00 |
| Mar 31, 2012 | -70,717.00 |
| Dec 31, 2011 | -63,589.00 |
| Sep 30, 2011 | -56,013.50 |
| Jun 30, 2011 | -60,455.50 |
| Mar 31, 2011 | -54,511.00 |